Oxysterols from a Marine Sponge Inflatella sp and Their Action in 6-Hydroxydopamine-Induced Cell Model of Parkinson's Disease

被引：11
|
作者：
Kolesnikova, Sophia A. [1 ]
Lyakhova, Ekaterina G. [1 ]
Kalinovsky, Anatoly I. [1 ]
Popov, Roman S. [1 ]
Yurchenko, Ekaterina A. [1 ]
Stonik, Valentin A. [1 ,2 ]
机构：
[1] GB Elyakov Pacific Inst Bioorgan Chem PIBOC, Prospect 100 Let Vladivostoku 159, Vladivostok 690022, Russia
[2] Far Eastern Fed Univ, Sch Nat Sci, Sukhanova St 8, Vladivostok 690000, Russia
来源：
MARINE DRUGS | 2018年 / 16卷 / 11期
基金：
俄罗斯科学基金会;
关键词：
secondary metabolites; oxygenated steroids; marine sponge; Inflatella; NMR; ROS; Parkinson's disease; structure-activity relationship; SH-SY5Y CELLS; CHOLESTEROL; METABOLITES; STEROLS; RESVERATROL; INVOLVEMENT; APOPTOSIS; PRODUCTS;
D O I：
10.3390/md16110458
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Four new oxysterols 1-4 along with previously known oxygenated sterols 5-14 were isolated from the sponge Inflatella sp., collected from the Sea of Okhotsk. Structures of 1-4 were elucidated by the detailed NMR spectroscopic and mass-spectrometric analyses as well as by comparison of the corresponding experimental data with those reported in literature. The influence of compounds 1-14 on the viability of neuronal Neuro2a cells treated by 6-hydroxydopamine and reactive oxygen species (ROS) formation in these cells was investigated.
引用
收藏
页数：12
相关论文
共 50 条
  • [1] Neurosteroid dehydroepiandrosterone attenuates 6-hydroxydopamine-induced apoptosis in a cell model of Parkinson's disease
    Mehdizadeh, Anahita
    Aali, Bibi Shahnaz
    Hajializadeh, Zahra
    Torkzadeh-Mahani, Shima
    Esmaeili-Mahani, Saeed
    PHYSIOLOGY AND PHARMACOLOGY, 2019, 23 (03): : 166 - 173
  • [2] Progressive changes of orexin system in a rat model of 6-hydroxydopamine-induced Parkinson's disease
    Cui, Long-Biao
    Li, Bo-Wei
    Jin, Xiao-Hang
    Zhao, Lin
    Shi, Juan
    NEUROSCIENCE BULLETIN, 2010, 26 (05) : 381 - 387
  • [3] Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease
    Fu, Yuan
    Ito, Mikako
    Fujita, Yasunori
    Ito, Masafumi
    Ichihara, Masatoshi
    Masuda, Akio
    Suzuki, Yumi
    Maesawa, Satoshi
    Kajita, Yasukazu
    Hirayama, Masaaki
    Ohsawa, Ikuroh
    Ohta, Shigeo
    Ohno, Kinji
    NEUROSCIENCE LETTERS, 2009, 453 (02) : 81 - 85
  • [4] Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease
    Khan, Mohd. Moshahid
    Ahmad, Ajmal
    Ishrat, Tauheed
    Khan, M. Badruzzaman
    Hoda, Md. Nasrul
    Khuwaja, Gulrana
    Raza, Syed Shadab
    Khan, Andleeb
    Javed, Hayate
    Vaibhav, Kumar
    Islam, Fakhrul
    BRAIN RESEARCH, 2010, 1328 : 139 - 151
  • [5] The dosage of curcumin to alleviate movement symptoms in a 6-hydroxydopamine-induced Parkinson's disease rat model
    Liu, Xiaoyu
    Zhang, Hao
    Li, Chuanfen
    Chen, Zhibin
    Gao, Qian
    Han, Muxuan
    Zhao, Feng
    Chen, Dan
    Chen, Qiuyue
    Hu, Minghui
    Li, Zifa
    Wei, Sheng
    Geng, Xiwen
    HELIYON, 2023, 9 (06)
  • [6] Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson's disease
    Qiu, Jiewen
    Peng, Guoyou
    Tang, Yuting
    Li, Shiyin
    Liu, Zengfu
    Zheng, Jiayun
    Wang, Yunxin
    Liu, Hanqun
    Wei, Lijian
    Su, Yilin
    Lin, Yuwan
    Dai, Wei
    Zhang, Zhiling
    Chen, Xiang
    Ding, Liuyan
    Guo, Wenyuan
    Zhu, Xiaoqin
    Xu, Pingyi
    Mo, Mingshu
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 14
  • [7] MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson’s disease: neuroprotective strategies
    E. Grünblatt
    S. Mandel
    M. B. H. Youdim
    Journal of Neurology, 2000, 247 (Suppl 2) : II95 - II102
  • [8] Neuroprotective effect of hydroxysafflor yellow A on 6-hydroxydopamine-induced Parkinson's disease in rats
    Han, Bing
    Hu, Jia
    Shen, Jingyu
    Gao, Yonglin
    Lu, Yan
    Wang, Tian
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 714 (1-3) : 83 - 88
  • [9] Norharman exacerbates 6-hydroxydopamine-induced Parkinson's disease but cannot establish it alone
    Haghdoost-Yazdi, Hashem
    Movahedi, Mohadeseh
    Faraji, Ayda
    Sophiabadi, Mohamad
    PHYSIOLOGY AND PHARMACOLOGY, 2011, 15 (02): : 260 - 267
  • [10] MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease:: neuroprotective strategies
    Grünblatt, E
    Mandel, S
    Youdim, MBH
    JOURNAL OF NEUROLOGY, 2000, 247 : 95 - 102
12345